These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17270148)

  • 1. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
    Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
    Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
    Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
    Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone improves vascular function and reduces platelet activation in diabetic rats.
    Schafer A; Vogt C; Fraccarollo D; Widder J; Flierl U; Hildemann SK; Ertl G; Bauersachs J
    J Physiol Pharmacol; 2010 Feb; 61(1):45-52. PubMed ID: 20228414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
    Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
    Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.
    Tarhzaoui K; Valensi P; Boulakia FC; Lestrade R; Albertini JP; Behar A
    Diabetes Res Clin Pract; 2008 Jun; 80(3):335-43. PubMed ID: 18406000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T; Matsumoto T; Kamata K
    Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Balaraman R
    Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
    Landsberger M; Jantzen F; Könemann S; Felix SB
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
    Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
    J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
    Roan JN; Fang SY; Chang SW; Hsu CH; Huang CC; Chiou MH; Tsai YC; Lam CF
    J Vasc Surg; 2012 Nov; 56(5):1381-9.e1. PubMed ID: 22727844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
    Riad A; Unger D; Du J; Westermann D; Mohr Z; Sobirey M; Dorenkamp M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Jan; 554(1):40-5. PubMed ID: 17097634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.
    Flierl U; Schöpp C; Jaitner J; Bauersachs J; Schäfer A
    Thromb Res; 2010 Mar; 125(3):e93-9. PubMed ID: 19846210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
    Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
    Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
    Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats.
    Lu YL; Hu SJ; Shen ZJ; Shao YC
    Chin Med J (Engl); 2004 Aug; 117(8):1165-9. PubMed ID: 15361289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.